Cancer News and Research

Latest Cancer News and Research

Phase III trials indicate reversible cognitive side effects in brain metastases treatment

A substantial number of patients with brain metastases who experience cognitive side effects following radiation therapy may fully regain cognitive function, according to a pooled analysis of three large, phase III clinical trials.

29 Sep 2024

Extending survival in meningioma patients with innovative radiopharmaceutical therapy

A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with difficult-to-treat meningioma, a type of brain tumor.

29 Sep 2024

From patient to physician: EJ Beck's medical journey at NYU Langone Health

As a child, EJ Beck was treated for a rare pediatric thyroid cancer at NYU Langone Health. About 10 years after the scan that declared her cancer-free, Beck was accepted into her No. 1 choice for a medical school: NYU Grossman School of Medicine.

27 Sep 2024

UCLA Health researchers showcase advances in radiation oncology at ASTRO

UCLA Health Jonsson Comprehensive Cancer Center researchers and physicians who specialize in treating patients with radiation therapies will present data on the latest radiation oncology research and clinical trial results at the 66th annual American Society for Radiation Oncology (ASTRO) meeting in Washington D.C., Sept. 29 to Oct. 2.

27 Sep 2024

University of Texas MD Anderson Cancer Center launches new journal on cancer education

The University of Texas MD Anderson Cancer Center today announced its first-ever academic journal, Advances in Cancer Education & Quality Improvement (ACE-QI). The journal will publish research, training program summaries and quality improvement interventions for the oncology provider community.

27 Sep 2024

Disruption of circadian clock linked to accelerated colorectal cancer progression

Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body's internal, 24-hour biological pacemaker, may accelerate the progression of colorectal cancer by affecting the gut microbiome and intestinal barrier function.

27 Sep 2024

Estrogen found to promote tumor growth in breast cancers without receptors

Estrogens are known to drive tumor growth in breast cancer cells that carry its receptors, but a new study by Duke Cancer Institute researchers unexpectedly finds that estrogens play a role in fueling the growth of breast cancers without the receptors, as well as numerous other cancers.

27 Sep 2024

Defective DNA repair mechanism linked to Huntington's disease progression

Researchers with McMaster University have discovered that the protein mutated in patients with Huntington's Disease doesn't repair DNA as intended, impacting the ability of brain cells to heal themselves.

27 Sep 2024

Novel approach combines glutaminase and HuR blockade to suppress breast cancer growth

A study led by Brazilian researchers and reported in an article published in the journal Nature Communications proposes that simultaneously targeting the enzyme glutaminase and the protein HuR, both of which are essential to tumor progression, may be effective in treating breast cancer.

27 Sep 2024

Study reveals rising pharmaceutical industry sponsored clinical trials in the U.S.

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in pharmaceutical industry sponsored clinical trials compared to those conducted with federal government support.

27 Sep 2024

Genolier Innovation Hub opens as a leading center for research and innovation in Europe

Located in BioAlps Health Valley, the Genolier Innovation Hub promotes collaboration in health sciences, aiming to redefine medical standards and patient care.

27 Sep 2024

'Treating Naturally Occurring Disease’, explained by Founder, Professor Noel Fitzpatrick

Humanimal Trust advocates for studying naturally occurring diseases in animals to advance cancer and osteoarthritis treatments for both humans and animals.

27 Sep 2024

Hormone hepcidin identified as potential trigger for psoriasis

Scientists may have uncovered the root cause of psoriasis, a chronic and sometimes debilitating skin disease that affects 2-3% of the global population. The condition is characterized by red, scaly patches that impact the quality of a patient's life and can sometimes be life-threatening.

26 Sep 2024

New insights into serine hydroxymethyltransferase aid cancer drug design

In just two neutron experiments, scientists discovered remarkable details about the function of an enzyme that can aid drug design for aggressive cancers.

26 Sep 2024

Gut bacteria influence symptoms of hypopituitarism in mice

Researchers at the Francis Crick Institute have shown that the balance of bacteria in the gut can influence symptoms of hypopituitarism in mice.

26 Sep 2024

Patient-derived gut organoids reveal new insights into Crohn's disease subtypes

Crohn's disease - an autoimmune disorder - is characterized by chronic inflammation of the digestive tract, resulting in a slew of debilitating gastrointestinal symptoms that vary from patient to patient.

26 Sep 2024

Study offers new insight into the link between oral microbiome and head and neck cancers

More than a dozen bacterial species among the hundreds that live in people's mouths have been linked to a collective 50% increased chance of developing head and neck squamous cell carcinoma (HNSCC), a new study shows.

26 Sep 2024

Study reveals positive correlation between type 2 immunity and long-term cancer remission

Results from a preclinical study in mice, led by EPFL, and a collaborative clinical study in patients show that the type 2 immune response – associated with parasitic infection and thought to play a negative role in cancer immunity – is positively correlated with long-term cancer remission.

26 Sep 2024

Antiviral drug molnupiravir linked to new mutations in SARS-CoV-2

Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has shown.

26 Sep 2024

Ultra-processed foods are silently altering your metabolism, scientists warn

Researchers from Germany and France uncover how ultra-processed foods impact metabolism in adolescents and young adults by analyzing urine and plasma biomarkers. Their findings suggest potential health risks linked to frequent consumption of processed foods.

26 Sep 2024

Cancer News and Research

Latest Cancer News and Research

Phase III trials indicate reversible cognitive side effects in brain metastases treatment

Extending survival in meningioma patients with innovative radiopharmaceutical therapy

From patient to physician: EJ Beck's medical journey at NYU Langone Health

UCLA Health researchers showcase advances in radiation oncology at ASTRO

University of Texas MD Anderson Cancer Center launches new journal on cancer education

Disruption of circadian clock linked to accelerated colorectal cancer progression

Estrogen found to promote tumor growth in breast cancers without receptors

Defective DNA repair mechanism linked to Huntington's disease progression

Novel approach combines glutaminase and HuR blockade to suppress breast cancer growth

Study reveals rising pharmaceutical industry sponsored clinical trials in the U.S.

Genolier Innovation Hub opens as a leading center for research and innovation in Europe

'Treating Naturally Occurring Disease’, explained by Founder, Professor Noel Fitzpatrick

Hormone hepcidin identified as potential trigger for psoriasis

New insights into serine hydroxymethyltransferase aid cancer drug design

Gut bacteria influence symptoms of hypopituitarism in mice

Patient-derived gut organoids reveal new insights into Crohn's disease subtypes

Study offers new insight into the link between oral microbiome and head and neck cancers

Study reveals positive correlation between type 2 immunity and long-term cancer remission

Antiviral drug molnupiravir linked to new mutations in SARS-CoV-2

Ultra-processed foods are silently altering your metabolism, scientists warn

Understanding the DNA Damage Response in Innate Immunity eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in